te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8(2):141–54.
Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause. 2004;11(6 Part 1 of 2):607–14.
PubMed
Google Scholar
Dolleman M, Faddy MJ, van Disseldorp J, van der Schouw YT, Messow CM, Leader B, Peeters PH, McConnachie A, Nelson SM, Broekmans FJ. The relationship between anti-Mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Endocrinol Metab. 2013;98(5):1946–53.
CAS
PubMed
Google Scholar
Bleil ME, Gregorich SE, McConnell D, Rosen MP, Cedars MI. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause. 2013;20(11):1139–46.
PubMed
PubMed Central
Google Scholar
de Kat AC, Verschuren WM, Eijkemans MJ, van der Schouw YT, Broekmans FJ. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study. Hum Reprod. 2016;31(8):1866–74.
PubMed
Google Scholar
Tehrani FR, Erfani H, Cheraghi L, Tohidi M, Azizi F. Lipid profiles and ovarian reserve status: a longitudinal study. Hum Reprod. 2014;29(11):2522–9.
CAS
PubMed
Google Scholar
de Kat AC, Verschuren WM, Eijkemans MJC, Broekmans FJM, van der Schouw YT. Anti-Mullerian hormone trajectories are associated with cardiovascular disease in women. Circulation. 2017;135(6):556–65.
PubMed
Google Scholar
Dam V, van der Schouw YT, Onland-Moret NC, Groenwold RHH, Peters SAE, Burgess S, Wood AM, Chirlaque M-D, Moons KGM, Oliver-Williams C, et al. Association of menopausal characteristics and risk of coronary heart disease: a pan-European case–cohort analysis. Int J Epidemiol. 2019;48(4):1275–85.
PubMed
PubMed Central
Google Scholar
Yarde F, Group tOS, Spiering W, Group tOS, Franx A, Group tOS, Visseren FLJ, Group tOS, Eijkemans MJC, Group tOS et al: Association between vascular health and ovarian ageing in type 1 diabetes mellitus. Hum Reprod 2016, 31(6):1354–1362.
Anderson EL, Fraser A, McNally W, Sattar N, Lashen H, Fleming R, Nelson SM, Lawlor DA. Anti-mullerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS One. 2013;8(5):e64510.
CAS
PubMed
PubMed Central
Google Scholar
Ramezani Tehrani F, Montazeri SA, Khalili D, Cheraghi L, Broekmans FJ, Momenan AA, de Kat AC, Azizi F. Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery disease. Climacteric. 2016;19(4):344–8.
CAS
PubMed
Google Scholar
Park HT, Cho GJ, Ahn KH, Shin JH, Kim YT, Hur JY, Kim SH, Lee KW, Kim T. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol. 2010;72(1):26–31.
CAS
Google Scholar
Akbaraly T, Wurtz P, Singh-Manoux A, Shipley MJ, Haapakoski R, Lehto M, Desrumaux C, Kahonen M, Lehtimaki T, Mikkila V, et al. Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies. Sci Rep. 2018;8(1):8620.
PubMed
PubMed Central
Google Scholar
Wurtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, Ghorbani A, Artati A, Wang Q, Tiainen M, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774–85.
PubMed
PubMed Central
Google Scholar
Deelen J, Kettunen J, Fischer K, van der Spek A, Trompet S, Kastenmuller G, Boyd A, Zierer J, van den Akker EB, Ala-Korpela M, et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat Commun. 2019;10(1):3346.
PubMed
PubMed Central
Google Scholar
Wurtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic Technologies. Am J Epidemiol. 2017;186(9):1084–96.
PubMed
PubMed Central
Google Scholar
Wurtz P, Wang Q, Kangas AJ, Richmond RC, Skarp J, Tiainen M, Tynkkynen T, Soininen P, Havulinna AS, Kaakinen M, et al. Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med. 2014;11(12):e1001765.
PubMed
PubMed Central
Google Scholar
Wurtz P, Tiainen M, Makinen VP, Kangas AJ, Soininen P, Saltevo J, Keinanen-Kiukaanniemi S, Mantyselka P, Lehtimaki T, Laakso M, et al. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012;35(8):1749–56.
CAS
PubMed
PubMed Central
Google Scholar
Wang Q, Wurtz P, Auro K, Makinen VP, Kangas AJ, Soininen P, Tiainen M, Tynkkynen T, Jokelainen J, Santalahti K, et al. Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med. 2016;14(1):205.
PubMed
PubMed Central
Google Scholar
Wang Q, Ferreira DLS, Nelson SM, Sattar N, Ala-Korpela M, Lawlor DA. Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Med. 2018;16(1):17.
PubMed
PubMed Central
Google Scholar
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–18.
PubMed
PubMed Central
Google Scholar
Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94(3):1044–51.
PubMed
Google Scholar
Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R, Jarvelin MR, Kahonen M, Lehtimaki T, Viikari J, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781–5.
CAS
PubMed
Google Scholar
Fischer K, Kettunen J, Wurtz P, Haller T, Havulinna AS, Kangas AJ, Soininen P, Esko T, Tammesoo ML, Magi R, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med. 2014;11(2):e1001606.
PubMed
PubMed Central
Google Scholar
White SL, Pasupathy D, Sattar N, Nelson SM, Lawlor DA, Briley AL, Seed PT, Welsh P, Poston L. Metabolic profiling of gestational diabetes in obese women during pregnancy. Diabetologia. 2017;60(10):1903–12.
CAS
PubMed
PubMed Central
Google Scholar
Mills HL, Patel N, White SL, Pasupathy D, Briley AL, Santos Ferreira DL, Seed PT, Nelson SM, Sattar N, Tilling K, et al. The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK Pregnancies Better Eating and Activity Trial (UPBEAT) randomised controlled trial. BMC Med. 2019;17(1):15.
PubMed
PubMed Central
Google Scholar
Pearce N, Lawlor DA. Causal inference-so much more than statistics. Int J Epidemiol. 2016;45(6):1895–903.
PubMed
Google Scholar
Williamson EJ, Aitken Z, Lawrie J, Dharmage SC, Burgess JA, Forbes AB. Introduction to causal diagrams for confounder selection. Respirology (Carlton, Vic). 2014;19(3):303–11.
Google Scholar
Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, et al. The international glossary on infertility and fertility care, 2017. Human Reproduction (Oxford, England). 2017;32(9):1786–801.
Google Scholar
Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–73.
CAS
PubMed
PubMed Central
Google Scholar
Zhu T, Goodarzi MO. SUN-016 Mendelian randomization reveals that polycystic ovary syndrome is not a causal risk factor for type 2 diabetes, coronary heart disease, or stroke. J Endocr Soc. 2020;4(Suppl 1):SUN-016.
PubMed Central
Google Scholar
Pearce N, Lawlor DA. Causal inference—so much more than statistics. Int J Epidemiol. 2017;45(6):1895–903.
PubMed Central
Google Scholar
Appt SE, Chen H, Clarkson TB, Kaplan JR. Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis. Menopause. 2012;19(12):1353–9.
PubMed
PubMed Central
Google Scholar
Looby SE, Fitch KV, Srinivasa S, Lo J, Rafferty D, Martin A, Currier JC, Grinspoon S, Zanni MV. Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV. AIDS (London, England). 2016;30(3):383–93.
CAS
Google Scholar
Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G, Romanik M, Olszanecka-Glinianowicz M. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstetrics Gynecol Reproductive Biol. 2011;158(2):254–9.
Google Scholar
Feldman RA, O’Neill K, Butts SF, Dokras A. Antimullerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome. Fertil Steril. 2017;107(1):276–81.
CAS
PubMed
Google Scholar
Cui Y, Shi Y, Cui L, Han T, Gao X, Chen Z-J. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome. Fertility Sterility. 2014;102(1):230–6 e232.
CAS
PubMed
Google Scholar
Cui L, Qin Y, Gao X, Lu J, Geng L, Ding L, Qu Z, Zhang X, Chen Z-J. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Fertility Sterility. 2016;105(2):481–5 e481.
CAS
PubMed
Google Scholar
McLennan IS, Pankhurst MW. Anti-Mullerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J Endocrinol. 2015;226(3):R45–57.
CAS
PubMed
Google Scholar
Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398–406.
PubMed
Google Scholar
Tobias DK, Mora S, Verma S, Lawler PR. Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis. Curr Opin Cardiol. 2018;33(5):558–64.
PubMed
PubMed Central
Google Scholar
Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, Haynes C, Dungan J, Newby LK, Hauser ER, Ginsburg GS, et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet. 2010;3(2):207–14.
CAS
PubMed
Google Scholar
Magnusson M, Lewis GD, Ericson U, Orho-Melander M, Hedblad B, Engstrom G, Ostling G, Clish C, Wang TJ, Gerszten RE, et al. A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J. 2013;34(26):1982–9.
CAS
PubMed
Google Scholar
Ruiz-Canela M, Toledo E, Clish CB, Hruby A, Liang L, Salas-Salvado J, Razquin C, Corella D, Estruch R, Ros E, et al. Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED Trial. Clin Chem. 2016;62(4):582–92.
CAS
PubMed
PubMed Central
Google Scholar
Iliodromiti S, Anderson RA, Nelson SM: Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update 2015;21(6):698–710. https://doi.org/10.1093/humupd/dmu062. Epub 2014 Dec 8.
Sovio U, Goulding N, McBride N, Cook E, Gaccioli F, Charnock-Jones DS, Lawlor DA, Smith GCS. A maternal serum metabolite ratio predicts fetal growth restriction at term. Nat Med. 2020;26(3):348–53.
CAS
PubMed
Google Scholar